Literature DB >> 32827558

Multimodal stratified imaging of nanovaccines in lymph nodes for improving cancer immunotherapy.

Rui Tian1, Chaomin Ke2, Lang Rao3, Joseph Lau3, Xiaoyuan Chen4.   

Abstract

Vaccines hold enormous potential in cancer immunotherapy by stimulating the body's immune response; unfortunately, the clinical response rates of cancer vaccines are less than 30%. Nanovaccines show the potential to enhance the treatment efficacy of conventional vaccines due to their unique properties, such as efficient co-delivery of cocktail to the secondary lymphatic system, high tumor accumulation and penetration, and customizable delivery of antigens and adjuvants. Meanwhile, the non-invasive visualization of vaccines after their delivery can yield information about in vivo distribution and performance, and aid in their subsequent optimization and translational studies. In this review, we summarize the strategies for the spatiotemporal visualization of nanovaccines in lymph nodes, including whole-body in vivo imaging, intravital organ/cell imaging, and ex vivo tissue/cell imaging. The application of imaging modalities in nanovaccine development is discussed. Moreover, strategies to achieve different combinations of imaging modalities are proposed. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32827558     DOI: 10.1016/j.addr.2020.08.009

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  4 in total

Review 1.  Multimodality imaging of nanoparticle-based vaccines: Shedding light on immunology.

Authors:  Muhsin H Younis; Zhongmin Tang; Weibo Cai
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2022-05-02

Review 2.  The bright future of nanotechnology in lymphatic system imaging and imaging-guided surgery.

Authors:  Shaolong Qi; Xinyu Wang; Kun Chang; Wenbin Shen; Guocan Yu; Jianshi Du
Journal:  J Nanobiotechnology       Date:  2022-01-06       Impact factor: 10.435

3.  Cancer nanomedicine.

Authors:  Sangeeta N Bhatia; Xiaoyuan Chen; Marina A Dobrovolskaia; Twan Lammers
Journal:  Nat Rev Cancer       Date:  2022-08-08       Impact factor: 69.800

4.  Responsive Multivesicular Polymeric Nanovaccines that Codeliver STING Agonists and Neoantigens for Combination Tumor Immunotherapy.

Authors:  Ting Su; Furong Cheng; Jialong Qi; Yu Zhang; Shurong Zhou; Lei Mei; Shiwei Fu; Fuwu Zhang; Shuibin Lin; Guizhi Zhu
Journal:  Adv Sci (Weinh)       Date:  2022-06-16       Impact factor: 17.521

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.